Agenus Inc reports results for the quarter ended in June - Earnings Summary

Agenus

08/08/2024 14:53

* Agenus Inc  AGEN.OQ  reported a quarterly adjusted loss of
$2.52​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of
$-4.00.  The mean expectation of five analysts for the quarter
was for a loss of $1.44 per share. Wall Street expected
results to range from $-2.89 to -2 cents per share.
    * Revenue fell 7.1% to $23.51 million from a year ago;
analysts
expected $61.48 million. 
    * Agenus Inc's reported EPS for the quarter was a loss of
$2.52​.
    * The company reported a quarterly loss of $54.8 million.
    * Agenus Inc shares had fallen by 69.7% this quarter and
lost 69.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 11.8%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Agenus Inc is
$8.50 
This summary was machine generated from LSEG data August 8 at
01:53 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -1.44          -2.52          Missed
 Mar. 31 2024      -3.22          -3.04          Beat
 Dec. 31 2023      -1.05          -2.60          Missed
 Sep. 30 2023      -3.84          -3.20          Beat